The fine-Tuning of TRAF2-GSTP1-1 interaction: Effect of ligand binding and in situ detection of the complex

Cell Death and Disease

Volumn 5, Issue 1, 2014, Pages

  De Luca, A ^a   Mei, G ^a   Rosato, N ^a   Nicolai, E ^a   Federici, L ^b   Palumbo, C ^a   Pastore, A ^c   Serra, M ^d   Caccuri, A M ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

GST; MAPK; NBDHEX; Osteosarcoma; Traf

Indexed keywords

GLUTATHIONE; GLUTATHIONE TRANSFERASE P1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2;

ARTICLE; BINDING AFFINITY; BINDING SITE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; COMPLEX FORMATION; CONTROLLED STUDY; DISSOCIATION CONSTANT; ENZYME ACTIVE SITE; ENZYME INACTIVATION; ENZYME SUBSTRATE COMPLEX; FLUORESCENCE ANALYSIS; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; HYDROPHOBICITY; LIGAND BINDING; M PHASE CELL CYCLE CHECKPOINT; OXIDATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; U2OS CELL LINE;

EID: 84906910160     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.529;     Document Type: Article

References (43)

1. Bradley JR, Pober JS. Tumor necrosis factor receptor-Associated factors (TRAFs). Oncogene 2001; 20: 6482-6491.
2. Chung JY, Park YC, Ye H, Wu H. All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction. J Cell Sci 2002; 115(Pt 4): 679-688.
3. Xie P. TRAF molecules in cell signaling and in human diseases. J Mol Signal 2013; 8: 7.
4. Park YC, Burkitt V, Villa AR, Tong L, Wu H. Structural basis for self-Association and receptor recognition of human TRAF2. Nature 1999; 398: 533-538.
5. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF et al. The stressactivated protein kinase subfamily of c-Jun kinases. Nature 1994; 369: 156-160.
6. Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ, Leder P. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 1998; 8: 297-303.
7. Zhang L, Blackwell K, Altaeva A, Shi Z, Habelhah H. TRAF2 phosphorylation promotes NF-kappaB-dependent gene expression and inhibits oxidative stress-induced cell death. Mol Biol Cell 2011; 22: 128-140.
8. Song HY, Ré gnier CH, Kirschning CJ, Goeddel DV, Rothe M. Tumor necrosis factor (TNF)- mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-Terminal kinase (JNK/SAPK) pathways at TNF receptor-Associated factor 2. Proc Natl Acad Sci USA 1997; 94: 9792-9796.
9. Hoeflich KP, Yeh WC, Yao Z, Mak TW, Woodgett JR. Mediation of TNF receptorassociated factor effector functions by apoptosis signal-regulating kinase-1 (ASK1). Oncogene 1999; 18: 5814-5820.
10. Nishitoh H, Saitoh M, Mochida Y, Takeda K, Nakano H, Rothe M et al. ASK1 is essential for JNK/SAPK activation by TRAF2. Mol Cell 1998; 2: 389-395.
11. Liu H, Nishitoh H, Ichijo H, Kyriakis JM. Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-Associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin. Mol Cell Biol 2000; 20: 2198-2208.
12. Chandel NS, Schumacker PT, Arch RH. Reactive oxygen species are downstream products of TRAF-mediated signal transduction. J Biol Chem 2001; 276: 42728-42736.
13. Noguchi T, Takeda K, Matsuzawa A, Saegusa K, Nakano H, Gohda J et al. Recruitment of tumor necrosis factor receptor-Associated factor family proteins to apoptosis signal-regulating kinase 1 signalosome is essential for oxidative stress-induced cell death. J Biol Chem 2005; 280: 37033-37040.
14. Tobiume K, Saitoh M, Ichijo H. Activation of apoptosis signal-regulating kinase 1 by the stress-induced activating phosphorylation of pre-formed oligomer. J Cell Physiol 2002; 191: 95-104.
15. De Luca A, Federici L, De Canio M, Stella L, Caccuri AM. New insights into the mechanism of JNK1 inhibition by glutathione transferase P1-1. Biochemistry 2012; 51: 7304-7312.
16. Sau A, Pellizzari Tregno F, Valentino F, Federici G, Caccuri AM. Glutathione transferases and development of new principles to overcome drug resistance. Arch Biochem Biophys 2010; 500: 116-122.
17. Wu Y, Fan Y, Xue B, Luo L, Shen J, Zhang S et al. Human glutathione S-Transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. Oncogene 2006; 25: 5787-5800.
18. Sau A, Filomeni G, Pezzola S, Serra M, D'Aguanno S, Tregno FP et al. Targeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and -resistant human osteosarcoma cell lines. Mol Biosyst 2012; 8: 994.
19. Xia Y, Makris C, Su B, Li E, Yang J, Nemerow GR et al. MEK kinase 1 is critically required for c-Jun N-Terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration. Proc Natl Acad Sci USA 2000; 97: 5243-5248.
20. Venyaminov SY, Baikalov IA, Shen ZM, Wu CS, Yang JT. Circular dichroic analysis of denatured proteins: inclusion of denatured proteins in the reference set. Anal Biochem 1993; 214: 17-24.
21. Masters BR, Lakowicz JR. Principles of fluorescence spectroscopy, third edition.J BiomedOpt 2008; 13: 029901.
22. Ivanetich KM, Goold RD. A rapid equilibrium random sequential bi-bi mechanism for human placental glutathione S-Transferase. Biochim Biophys Acta 1989; 998: 7-13.
23. Adler V, Yin Z, Fuchs SY, Benezra M, Rosario L, Tew KD et al. Regulation of JNK signaling by GSTp. EMBO J 1999; 18: 1321-1334.
24. Ricci G, Del Boccio G, Pennelli A, Lo Bello M, Petruzzelli R, Caccuri AM et al. Redox forms of human placenta glutathione transferase. J Biol Chem 1991; 266: 21409-21415.
25. Turella P, Cerella C, Filomeni G, Bullo A, De Maria F, Ghibelli L et al. Proapoptotic activity of new glutathione S-Transferase inhibitors. Cancer Res 2005; 65: 3751-3761.
26. Ricci G, De Maria F, Antonini G, Turella P, Bullo A, Stella L et al. 7-Nitro-2, 1, 3-benzoxadiazole derivatives, a new class of suicide inhibitors for glutathione S-Transferases. Mechanism of action of potential anticancer drugs. J Biol Chem 2005; 280: 26397-26405.
27. Söderberg O, Gullberg M, Jarvius M, Ridderstrale K, Leuchowius K-J, Jarvius J et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods 2006; 3: 995-1000.
28. Sundqvist A, Zieba A, Vasilaki E, Herrera Hidalgo C, Soderberg O, Koinuma D et al. Specific interactions between Smad proteins and AP-1 components determine TGFbinduced breast cancer cell invasion. Oncogene 2012; 32: 3606-3615.
29. Pellizzari Tregno F, Sau A, Pezzola S, Geroni C, Lapenta C, Spada M et al. In vitro and in vivo efficacy of 6-(7-nitro-2, 1, 3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) on human melanoma. Eur J Cancer 2009; 45: 2606-2617.
30. Battisti S, Valente D, Albonici L, Bei R, Modesti A, Palumbo C. Nutritional stress and arginine auxotrophy confer high sensitivity to chloroquine toxicity in mesothelioma cells. Am J Respir Cell Mol Biol 2012; 46: 498-506.
31. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012; 8: 445-544.
32. Stella L, Caccuri AM, Rosato N, Nicotra M, Lo Bello M, De Matteis F et al. Flexibility of helix 2 in the human glutathione transferase P1-1. time-resolved fluorescence spectroscopy. J Biol Chem 1998; 273: 23267-23273.
33. Federici L, Lo Sterzo C, Pezzola S, Di Matteo A, Scaloni F, Federici G et al. Structural basis for the binding of the anticancer compound 6-(7-nitro-2, 1, 3-benzoxadiazol-4-ylthio)hexanol to human glutathione s-Transferases. Cancer Res 2009; 69: 8025-8034.
34. Tew KD, Monks A, Barone L, Rosser D, Akerman G, Montali JA et al. Glutathioneassociated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program. Mol Pharmacol 1996; 50: 149-159.
35. Yang JT, Wu CS, Martinez HM. Calculation of protein conformation from circular dichroism. Methods Enzymol 1986; 130: 208-269.
36. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-Transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974; 249: 7130-7139.
37. Stella L, van de Weert M. Fluorescence quenching and ligand binding: A critical discussion of a popular methodology. J Mol Struct 2011; 998: 144-150.
38. Sánchez del Pino M, Farràs R, Ferrero M, Valero L, Orlando L, Font de Mora J et al. Phosphorylation of AIB1 at mitosis is regulated by CDK1/CYCLIN B. PLoS One 2011; 6: e28602.
39. Kim J-S, Park Y-Y, Park S-Y, Cho H, Kang D, Cho H. The auto-ubiquitylation of E3 ubiquitin-protein ligase Chfr at G2 phase is required for accumulation of polo-like kinase 1 and mitotic entry in mammalian cells. J Biol Chem 2011; 286: 30615-30623.
40. Gabellini D, Colaluca IN, Vodermaier HC, Biamonti G, Giacca M, Falaschi A et al. Early mitotic degradation of the homeoprotein HOXC10 is potentially linked to cell cycle progression. EMBO J 2003; 22: 3715-3724.
41. Pastore A, Tozzi G, Gaeta LM, Bertini E, Serafini V, Di Cesare S et al. Actin glutathionylation increases in fibroblasts of patients with Friedreich's ataxia: A potential role in the pathogenesis of the disease. J Biol Chem 2003; 278: 42588-42595.
42. Aebersold R, Claassen M, Ellenberg J, Rinner O, Schmidt A, Ori A et al. The quantitative proteome of a human cell line. Mol Syst Biol 2011; 7: 549.
43. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990; 82: 1107-1112.